Compare MCHP & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHP | ZTS |
|---|---|---|
| Founded | 1989 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3B | 49.7B |
| IPO Year | 2003 | 2012 |
| Metric | MCHP | ZTS |
|---|---|---|
| Price | $97.69 | $78.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 12 |
| Target Price | $85.59 | ★ $154.18 |
| AVG Volume (30 Days) | ★ 9.5M | 5.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.02% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 1.42 |
| Revenue | $5,349,500,000.00 | ★ $9,467,000,000.00 |
| Revenue This Year | $8.12 | $5.63 |
| Revenue Next Year | $22.55 | $4.77 |
| P/E Ratio | ★ N/A | $58.37 |
| Revenue Growth | ★ 34.38 | 2.28 |
| 52 Week Low | $48.52 | $81.10 |
| 52 Week High | $105.91 | $172.23 |
| Indicator | MCHP | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 69.59 | 12.55 |
| Support Level | $61.65 | N/A |
| Resistance Level | N/A | $129.32 |
| Average True Range (ATR) | 4.15 | 3.24 |
| MACD | 0.70 | -4.07 |
| Stochastic Oscillator | 66.72 | 0.18 |
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.